This review highlights recent and ongoing discoveries that are transforming the previously held view of dyad structure and function. New data show that dyads vary greatly in both structure and in their associated molecules. Dyads can contain varying numbers of type 2 ryanodine receptor (RYR2) clusters that range in size from one to hundreds of tetramers and they can adopt numerous orientations other than the expected checkerboard. The association of Ca v 1.2 with RYR2, which defines the couplon, is not absolute, leading to a number of scenarios such as dyads without couplons and those in which only a fraction of the clusters are in couplons. Different dyads also vary in the transporters and exchangers with which they are associated producing functional differences that amplify their structural diversity. The essential role of proteins, such as junctophilin-2, calsequestrin, triadin, and junctin that maintain both the functional and structural integrity of the dyad have recently been elucidated giving a new mechanistic understanding of heart diseases, such as arrhythmias, hypertension, failure, and sudden cardiac death.
Introduction
Our understanding of how both familiar and newly identified molecules contribute to the structure and function of the dyad has been transformed in recent years. The function of these molecules, and their role in health and disease, has been elucidated using genetically modified animals and a number of new techniques. This review will highlight recent developments in the field, while noting that earlier reviews have detailed the fundamental observations and hypotheses which laid the foundation for our current progress. 1 -5 We will refer to the T-tubules as the transverse-axial tubule system (TATS) since it contains many axial as well as transverse elements, while the term sarcolemma will be restricted to the cell surface; plasmalemma will refer to both. This terminology reflects the need to distinguish between these areas of the membrane despite forming a continuous structure. The term dyad refers to the structural element formed by the close apposition of the sarolemma and the junctional sarcoplasmic reticulum (jSR), while a couplon is the functional element within the dyad formed by juxtaposition of type 2 ryanodine receptors (RYR2) in the jSR with cardiac L-type voltage-gated Ca 2+ channels (Ca v 1.2) in the adjacent plasmalemma.
Structure of the dyad and local control of ECC
Excitation-contraction coupling (ECC) is initiated by an influx of Ca 2+ through the Ca v 1.2 on the plasmalemma. This small influx of Ca 2+ triggers a much larger Ca 2+ release into the myoplasm through the RYR2 in the jSR, a mechanism of ECC called Ca 2+ -
induced Ca 2+ release (CICR). 6, 7 Even though CICR is a process of positive-feedback, an open RYR2 does not trigger all of the others leading to an explosive all-or-none event. This problem, dubbed the calcium paradox, was first solved theoretically by positioning RYR2 into groups of physically and functionally isolated clusters that were independently controlled. 8 Experimental support for this hypothesis followed rapidly. The first were observations describing Ca 2+ 'sparks', which are the result of stochastic openings of a small cluster of RYR2 that do not lead to all-or-nothing Ca 2+ transients. 9 -13 These were spatially isolated events encompassing a large volume that did not trigger Ca 2+ release from other dyads. Following this, electron microscopy and immunofluorescence analyses identified clusters of Ca v 1.2 in the plasmalemma-situated opposite clusters of RYR2 in the jSR; the two being separated by 15 nm. 14, 15 The Ca 2+ sparks and the structural analyses provided the basis for local control theory, which states that Ca 2+ release from one couplon does not affect the others because of the physical separation between them and the high local Ca 2+ required to activate RYR2. ECC and local control theory are discussed in detail by Bers.
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The fundamental event in ECC is a Ca 2+ spark, and a Ca 2+ transient is the macroscopic sum of thousands of sparks. This enables the force of contraction to be a function of the number of sparks that are initiated, equivalent to the number of couplons that are recruited. At the time these theories were formulated a dyad was thought to contain a single large couplon, but new discoveries require that some of these ideas be re-examined. However, the concept that CICR is a result of, and is dependent on, the molecular composition, architecture, and distribution of the dyads remains unchallenged. Dyads are found throughout mammalian myocytes with a welldeveloped TATS, which includes the ventricles, and the atria of larger species. 17, 18 The presence of a TATS seems to be determined by the size of the myocyte; even in small mammals the larger atrial myocytes are more likely than not to have a rudimentary TATS when the cells are greater than about 10 mm wide. 19 Myocytes without a TATS have corbular SR (extra-junctional SR), which are sacs of SR decorated with RYR2 projecting into the myoplasm. These are positioned along the Z-line and can release Ca 2+ in response to Ca 2+ diffusion from sarcolemmal dyads, functioning as a secondary amplification system. The jSR always appears as a narrow sac that is relatively flattened when adjacent to the sarcolemma, but it can adopt a number of configurations around the TATS, forming dyads, triads, and more complex geometries, including junctions that span an entire sarcomere. 20 The lumen of the jSR contains electron dense material, which is largely composed of the Ca 2+ -binding protein calsequestrin (CASQ). 21 The surface of the jSR facing the plasmalemma is populated by electron dense projections that extend most of the width of the dyadic cleft. These are the RYR2, also known as the foot processes. Their position and characteristic shape make them one of the few proteins that can be positively identified in standard transmission electron microscopy (TEM); some examples are presented in Figure 1 .
Ryanodine receptors
The RYR2 gene encodes a large 565 kDa protein that forms homotetramers creating RYR2, the SR Ca 2+ release channels whose molecular weight is 2.2 MDa. Mammals express three isoforms (RYR1-3), with the working myocardium expressing only RYR2. 22 -25 The isoforms are highly homologous, with rabbit RYR2 sharing 70% amino acid identity with RYR1 and RYR3. 22, 23 Cryo-electron microscopy of RYR1 demonstrates that 80% of the protein extends into the myoplasm in the shape of a rectangular prism (29 × 29 × 13 nm) and has multiple solvent-accessible cavities. 26 -28 More recent work has revealed large allosteric movements associated with RYR1 gating, particularly in the clamp region (domains 5 -10) which moves 8 Å towards the surface of the SR. 29 The three isoforms have near identical three-dimensional structures, as expected from the large sequence similarity, so comparable gating movements are expected from RYR2. Additional structural details are available from recent reviews. 30 -34 In skeletal muscle triads, RYR1 are distributed in a checkerboard array whereby each tetramer contacts its neighbours through domains 6 and 10 in the protein's clamp region, 35 Figure 2 . In vitro experiments using purified RYR1 inserted into lipid bilayers have shown that the same lattice forms spontaneously, demonstrating this to be an intrinsic property of the molecule. 36 Since the clamps undergo major conformational changes as the channel opens and closes, they are likely contributing to allosteric interactions between neighbouring channels. 37 Thin section TEM of cardiac junctions has reported a reasonably regular spacing between the tetramers, comparable with that of skeletal muscle triads, 38 and coupled gating between RYR2s has been observed in vitro. 39 Because of this and the structural similarity to RYR1, RYR2 has also been thought to form a checkerboard lattice. However, recent electron tomographic analysis of rat ventricular myocytes fixed in situ has shown RYR2 distributed in a combination of checkerboard and side-by-side configurations with some isolated tetramers. 40, 41 This surprising arrangement seemed to be a combination of two RYR1 orientations observed in lipid bilayers, a checkerboard array at 0 mM Mg 2+ and a side-by-side orientation, where the tetramers were not in direct contact, at 4 mM Mg 2+ . 42 Since the in vivo Mg 2+ concentration is 1 mM, it could be that the in situ distribution is an intermediate arrangement between these two extremes. Part of domain 10 of the mouse RYR2 (residues 2699-2904) has recently been crystallized and its structure solved at 1.65-1.95 Å resolution. 43 This region hosts the phosphorylation sites S2808 and S2814 (human numbering), whose physiological and pathophysiological effects are the subject of intense controversy. 44 -46 This study identified five phosphorylation sites for PKA (S2797, S2808, T2810, S2811, and S2815) and four for CaMKII (S2808, S2811, S2814, and T2876), some of which overlap. A large-scale analysis of phosphorylated proteins in the mouse has identified all of these residues (except T2876), as well as T2781, Y2821, and S2822, as targets for in vivo phosphorylation. 47 The analyses demonstrate that multiple sites can be phosphorylated simultaneously, raising the possibility that functional effects could be cumulative and tuned by the number of sites involved. Tomographic data of mouse ventricle has provided surprising insights into the architecture of the dyad. 48 RYR2 were thought to fill the dyadic cleft, but occupy only 78% of it. The average volume of the dyadic cleft is an order of magnitude lower than previously thought (2.9 × 10 5 vs. 1.5 × 10 6 nm 3 38 ), ranging from a minimum of 9.3 × 10 3 nm 3 to a maximum of 3.9 × 10 6 nm 3 . Assuming a 12 nm wide cleft and side-by-side packing, 48 the maximum number of RYR2 that each cleft could contain ranges from one to a maximum of 385, with a mean occupancy of 43, while checkerboard packing gives a maximum of 226 and a mean of 25. The median was only 25 (15 checkerboard), indicating a distribution skewed by some large clefts. Super-resolution immunofluorescence of rat ventricle myocardium has shown a comparable result, with numerous smaller and irregularly shaped clusters of RYR2 averaging only 14 tetramers per cluster, with edge-to-edge intercluster distances often ,50 nm. 49 Neither study could resolve the distribution of individual tetramers within a cluster, although the latter used the checkerboard lattice as an a priori assumption with which to fit the data.
These new values represent a considerable drop from the previous estimate of 75 -100 tetramers/cluster. 38, 50 It has been difficult to explain why a Ca 2+ spark arises from roughly 7-20 tetramers, but the new observations indicate why this might be so, as this seems to be the approximate size of a cluster. However, this does not explain why Ca 2+ released from one cluster does not trigger neighboring clusters within the same dyadic cleft given the very small distances between them. This question is currently being investigated. 51 Centre-to-centre distances between 300 and 750 nm were found between RYR2 clusters using TEM and diffraction-limited fluorescence microscopy, 38, 50 whereas in the tomograms a large fraction are much closer than that. This raises the question of how close two clusters can be and remain functionally independent. These new data support a model of the dyad in which the RYR2 are distributed in a number of small clusters including single receptors, with the tetramers adopting multiple arrangements; this is diagrammed and contrasted with our earlier view of RYR2 distribution in Figure 3 . The functional implications of this structural organization, and how the Ca v 1.2 are distributed relative to the RYR2, have yet to be determined.
Ca v 1.2
Ca v 1.2 is a heterotetramer composed of a pore-forming a 1C subunit, one of the four b subunit isoforms which determine where in the plasmalemma the a subunit is targeted, an extracellular a 2 d subunit and a g subunit. 52 Immunofluorescence has indicated that 75% of Ca v 1.2 clusters in the rat ventricle are located in couplons. 53 They are smaller than the RYR2 clusters, and within the limits of diffractionlimited microscopy, appear to be positioned over their centres. 53 Functional analyses have suggested a tight physical association between Ca v 1.2 and RYR2. In these studies, Ca 2+ channel agonists increased, and antagonists decreased, the Ca 2+ spark frequency in permeabilized cells when there was no transmembrane Ca 2+ gradient or flow through the channel. 54, 55 This implies that Ca v 1.2 affects RYR2
gating through a direct physical interaction or through intermediary proteins. In support of this view, the C-terminus of the a 1C subunit binds directly to RYR2 with high affinity, 6 nM, and injecting it into atrial cells increases Ca 2+ spark frequency. 56, 57 These data suggest 68 Unpublished results from our laboratory indicate that the molecular architecture of the ventricular dyads are similarly diverse. NCX is anchored into the membrane, in part, by ankyrin-B, a multivalent adaptor protein that also binds and localizes the Na + /K + ATPase. 64, 69 Multiple experiments have demonstrated that the activities of the ouabain-sensitive a2 isoform of NKA and NCX are tightly coupled. 69 -71 These data demonstrate that the a2 isoform of NKA can affect Na + and Ca 2+ handling within the dyad and alter ECC, but the exact position relative to the dyad is unknown. A more detailed discussion of Ca v 1.2 and NCX, their positions relative to the dyad and the functional implications of the molecular architecture, has recently been published. 58 The myoplasmic domain of RYR2 is reported to scaffold at least 17 molecules that affect its activity. This includes kinases and their anchoring proteins, calmodulin, FKBP12, and 12.6, and soluble proteins like sorcin that can modify the channel's flux. This review will be limited to those that are important in determining the structural properties of the dyad, a complete description and analysis of the others can be found in recent reviews. 33 ,34,46
Junctophilin
An essential component of the dyadic cleft is the molecule junctophilin 2 (JPH2), one of a family of four isoforms which are present in the junctional membrane complexes of other excitable cells such as skeletal muscle (JPH1) or brain (JPH3 and 4). 72, 73 JPH2 is a 74 kDa molecule which spans the cleft from the plasmalemma to the SR, and plays the central role in the development and maintenance of that space. The end touching the plasma membrane has 8 MORN (Membrane On Receptor Nexus) sequences while the other end, the transmembrane domain, is embedded in the SR. The MORN sequence is highly conserved across species 74 and seems to be responsible for binding both to lipids and proteins in the t-tubular membrane. The section spanning the dyad cleft consists of an alpha-helix as well as a divergent region that is associated with the characteristics of each isoform ( Figure 4 ). There are a number putative phosphorylation sites on JPH2, but none have been associated with a particular function.
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JPH2 KO mice are embryonic lethal and fail at about the time the heart beat is established (E10.5); EM imaging shows that the distance between the plasmalemma and the membrane of the SR was increased compared with control embryos, 73 indicating that keeping the two membranes a fixed distance apart was a major function of this molecule. In skeletal muscle, there is evidence that JPH1 is linked to both Ca v 1.1 and RYR1, 77 but the exact relationship in cardiomyocytes is unclear; super-resolution images of JPH2 and RYR2 show differing distributions that vary from dyad to dyad, ranging from each RYR2 having a JPH2 adjacent to it, to having the JPH2 at the periphery of the dyad surrounding all of the RYR2 within it. 78 In mice in which knock-down of JPH2 was achieved using tamoxifen-induced siRNA, there was a 40% reduction in the number of dyads. 79 The width of the remaining dyadic clefts was, on average, no different than control, but displayed more variance, even within a single dyad ( These results suggest that JPH2 is not only responsible for maintaining the dyadic structure but was keeping the Ca v 1.2 positioned opposite the RyR2, a role similar to that in skeletal muscle. This would be consistent with recently reviewed functional and structural evidence pointing to a much closer physical association between Ca v 1.2 and RYR2 than previously thought.
The RYR macromolecular complex within the SR
RYR2 forms a macromolecular complex with a number of other molecules in the SR; the SR transmembrane proteins triadin and junctin, whose N-terminals extend a short way into the dyadic cleft and two SR-bound calcium storage molecules; calsequestrin (CASQ), a high affinity but low capacity calcium binder 80 and histidine-rich calciumbinding protein (HRC) which has a high capacity, but low affinity, for calcium. 81 Both of these storage molecules interact with junctin and triadin which, in turn, affect the ryanodine receptor and thus the behaviour of the dyad. Junctin 82 and triadin 83 have similar structures; the C-terminal domain of both molecules binds to RYR2 and CASQ forming a macromolecular complex. Triadin has disulphide bonds allowing it to form oligomers, and it is in this state that it anchors CASQ to the membrane of the jSR. It was initially thought that there were three cardiac triadins (CT1-3), with molecular weights of 35, 40, and 95 kDa, respectively.
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CT2 was later identified as glycosylated CT1, 84 and CT3 is ,5% of the total. A later analysis of mouse cardiac triadin reported three splice variants with molecular weights of 35, 35.5, and 40 kDa, and their functional significance remains unknown. 85 Although triadin-null mice appear to be normal and grow to maturity, such mice have fewer dyads with a smaller extent and less RYR2 than do wild-type. 86 These animals have reduced co-localization between Ca v 1.2 and RYR2, a reduced CASQ expression and an almost complete absence of junctin. In addition, they are susceptible to catecholaminergic polymorphic ventricular tachycardia (CPVT) due to an increased SR Ca 2+ leak. Recently, it has been shown that individuals who suffer mutations in triadin also suffer from CPVT resulting in sudden cardiac death. 87 Junctin-null mice appear to have few structural alterations and no changes in any other Ca 2+ handling
proteins, but are more susceptible to CPVT and die very young after as little as 5 weeks of life. 88 The difference with the triadin-null mice is remarkable given their similarities. Junctate, like junctin, is a splice variant of aspartyl beta-hydroxylase, but the differing charges on their C-terminals, positive for junctin and negative for junctate, mean that they serve different functions: junctin CASQ. There is evidence for both mechanisms, but which of the two, or a combination of both, actually controls the RYR2 open probability is still a matter of debate. 93 CASQ mutations in humans are well known to have deleterious effects with CPVT and sudden cardiac death being common outcomes. 94 CASQ null mice have a larger SR than normal; they are also subject to CPVT probably due to an increased SR leak as well as a reduction in control of the RYR2 P o . 95 The width of the jSR is wider in the CASQ null mice compared with the wild type. This characteristic is shared with the triadin nulls, but the down-regulation of CASQ expression suggests that the changes in the jSR are a secondary effect. The other calcium-binding protein in the SR, the HRC, is, like CASQ, highly charged and is thought to exert its calcium-binding properties through electrostatic interaction with pairs or triplets of amino acids. HRC binds with triadin through which it can modulate the behaviour of RYR2. HRC can also partner with SERCA, the ratio of the two proteins being determined by the luminal Ca 2+ concentration. In rat ventricular tissue, the amount of Ca 2+ binding to HRC constitutes a significant portion of the total. 92 HRC has a compensatory up-regulation when CASQ is ablated, 92 probably to provide additional Ca 2+ buffering.
Development of the dyad
In mammals, the T-tubules are absent at birth; in the rat, ventricular cardiomyocytes have no TATS at Day 10 but it is fully present by Day 20. 96 Electron microscope observations show that very little dihydropyridine receptor appears opposite the RYR early in development. 97 This fits well with the observations of developing rabbit myocardium where the peripheral couplings have NCX co-localized with RYR2 and reverse-mode calcium influx is the method whereby ECC is initiated. 63 As the animal matures, NCX expression declines 98 while the number and density of NCX clusters co-localized with RYR2 decreases. 63 In parallel, there is an increased co-localization of RYR2
with Ca v 1.2, 99 producing the adult form of CICR where I Ca initiates Ca 2+ release from RYR2. The first molecule that appears in the dyad is probably JPH2 which anchors the SR to the plasmalemma, then CASQ enters the SR lumen with triadin and junctin following shortly thereafter. 97 A study of developing T-tubules in the rat ventricular cardiomyocyte suggests that the TATS is generated in two ways; the majority penetrating into the cell along Z the lines while other tubules expand from small pockets of membrane containing Ca v 1.2 that form within the cell interior and eventually join existing RYR2 clusters. 100 
Structural alterations in disease
Gó mez et al. 101 were the first to hypothesize that contractile failure followed a structural change within the dyad. They found reduced coupling between Ca v 1.2 and RYR2 in hypertrophied hearts with no appreciable change in the cellular architecture, the density and function of either channel, or the SR Ca 2+ load, any of which might have produced the same effect. Recent data from studies of pressure-overloaded Sprague-Dawley rats support this hypothesis, and suggest that a reduction in the expression of JPH2 precedes the loss of Ca v 1.2 -RYR2 intercommunication on which both CICR and CDI depend. 102, 103 A loss of JPH2 would be expected to 'unglue' the jSR from the T-tubules and widen the dyadic cleft and this has been observed in a pressure-overloaded model of failure. 104 The initial uncoupling of RYR2 from Ca v 1.2 increases the distance between them, which should reduce the effectiveness of both CICR and CDI, which may explain Gó mez's observations. Additional evidence for the involvement of JPH2 comes from people suffering hypertrophic cardiac myopathy who have reduced concentrations of JPH2, 105 and a probable mechanism for this reduction is the up-regulation of microRNA, which reduces the expression of JPH2. 106 At later stages of disease, the TATS undergoes extensive remodelling eventually becoming fractured, convoluted, and disorganized, leaving isolated and 'orphaned' RYR2. The latter become subject to excitation via Ca 2+ diffusion, similar to its neonatal state, leading to unsynchronized Ca 2+ release, delayed after depolarizations, electrical malfunction, and death. 107 -110 Other studies have shown that heart failure is associated with a reduction in the size of the dyad 104 as well as a down-regulation of a slew of proteins, 111 including CASQ, junctin, NCX, and Ca v 1.2; the reduction in the latter two are probably the result of the reduced t-tubular volume. It has also been shown that action potential propagation in the TATS of rats suffering heart failure regularly fails even if the tubules remains attached to the sarcolemma. 112 
Summary
In little over a decade, our understanding of dyad architecture has been conceptually transformed from one in which the cleft was filled with hundreds of RYR2 tetramers arranged in a continuous checkerboard array forming a single couplon to one where dyads are both structurally and functionally diverse. Observations indicate that they contain multiple RYR2 clusters of varying sizes and tetramer organization and are associated with different channels and transporters that alter their function. Some RYR2 clusters do not have Ca v 1.2 opposite them and are therefore not in couplons, 53, 65, 113 suggesting that some dyads may not contain a couplon or that not all clusters within a dyad form couplons. Conversely, some dyads might house many couplons, producing additional functional diversity. With the application of new imaging techniques and the discovery of new molecules that support and modulate dyad structure and function, long-held hypotheses are being challenged. The functional implications of these discoveries are just beginning to be explored, but are likely to produce a new theoretical foundation from which to interpret the functioning of the myocyte in both health and disease. 
